Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database
- PMID: 9730422
Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database
Abstract
Background: Controversy exists regarding donor and recipient factors that promote the development and progression of coronary artery disease after heart transplantation and the likelihood of coronary artery disease causing death or retransplantation.
Methods: To investigate this issue in a large cohort of patients, we analyzed 5963 postoperative angiograms performed in 2609 of the 3837 patients undergoing heart transplantation at 39 institutions between January 1990 and December 1994. Coronary artery disease was classified as mild, moderate, or severe on the basis of left main involvement, primary vessel stenoses, and branch stenoses. Coronary artery disease was considered severe if left main stenosis was > 70% or 2 or more primary vessels stenoses were > 70% or branch stenoses were > 70% in all 3 systems.
Results: By the end of 5 years after heart transplantation, coronary artery disease was present in 42% of the patients, mild in 27%, moderate in 8%, and severe in 7%. Coronary artery disease-related events (death or retransplantation) had an actuarial incidence of 7% at 5 years and occurred in 2 of 3 of the patients with development of angiographically severe coronary artery disease. By multivariable logistic analysis, risk factors for donor coronary artery disease included older donor age (P < .0001) and donor hypertension (P=.0002). By multivariable analysis in the hazard function domain, risk factors identified for the earlier onset of allograft coronary artery disease included older donor age (P < .0001 ), donor male sex (P=.0006), donor hypertension (P=.07), recipient male sex (P=.02), and recipient black race (P=.01). The actuarial incidence of severe coronary artery disease was 9% at 5 years.
Conclusions: Angiographic coronary artery disease is very common after heart transplantation, occurring in approximately 42% of the patients by 5 years. Older donor age, donor hypertension, and male donor or recipient predict earlier onset of angiographic allograft coronary artery disease. Although severe angiographic allograft coronary artery disease occurs in only 7% of the patients at 5 years, its presence is highly predictive of subsequent coronary artery disease-related events or retransplantation.
Comment in
-
Prevalence and prognostic value of cardiac allograft vasculopathy 1 year after heart transplantation according to the ISHLT recommended nomenclature.J Heart Lung Transplant. 2012 Mar;31(3):332-3. doi: 10.1016/j.healun.2011.12.006. J Heart Lung Transplant. 2012. PMID: 22333404 No abstract available.
Similar articles
-
Cardiac transplant coronary artery disease. A multivariable analysis of pretransplantation risk factors for disease development and morbid events.J Thorac Cardiovasc Surg. 1995 Jun;109(6):1081-8; discussion 1088-9. doi: 10.1016/S0022-5223(95)70191-5. J Thorac Cardiovasc Surg. 1995. PMID: 7776672
-
Relation of donor age and preexisting coronary artery disease on angiography and intracoronary ultrasound to later development of accelerated allograft coronary artery disease.J Am Coll Cardiol. 1997 Mar 1;29(3):623-9. doi: 10.1016/s0735-1097(96)00521-9. J Am Coll Cardiol. 1997. PMID: 9060902
-
Diagnostic accuracy of coronary angiography and risk factors for post-heart-transplant cardiac allograft vasculopathy.Transplantation. 2003 Aug 27;76(4):679-82. doi: 10.1097/01.TP.0000071200.37399.1D. Transplantation. 2003. PMID: 12973108
-
European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.Eur Heart J Cardiovasc Imaging. 2015 Sep;16(9):919-48. doi: 10.1093/ehjci/jev139. Epub 2015 Jul 2. Eur Heart J Cardiovasc Imaging. 2015. PMID: 26139361 Review.
-
Cardiac allograft vasculopathy.Crit Care Nurs Q. 2004 Jan-Mar;27(1):10-6. doi: 10.1097/00002727-200401000-00002. Crit Care Nurs Q. 2004. PMID: 14974521 Review.
Cited by
-
Evaluation of coronary adventitial vasa vasorum using 3D optical coherence tomography--animal and human studies.Atherosclerosis. 2015 Mar;239(1):203-8. doi: 10.1016/j.atherosclerosis.2015.01.016. Epub 2015 Jan 20. Atherosclerosis. 2015. PMID: 25618027 Free PMC article.
-
Timing of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor initiation and allograft vasculopathy progression and outcomes in heart transplant recipients.ESC Heart Fail. 2018 Dec;5(6):1118-1129. doi: 10.1002/ehf2.12329. Epub 2018 Jul 17. ESC Heart Fail. 2018. PMID: 30019530 Free PMC article.
-
Ethnic disparity in Israel impacts long-term results after heart transplantation.Isr J Health Policy Res. 2019 Jan 14;8(1):3. doi: 10.1186/s13584-018-0271-7. Isr J Health Policy Res. 2019. PMID: 30636628 Free PMC article.
-
Lipoprotein-associated phospholipase A2 predicts progression of cardiac allograft vasculopathy and increased risk of cardiovascular events in heart transplant patients.Transplantation. 2008 Apr 15;85(7):963-8. doi: 10.1097/TP.0b013e3181684319. Transplantation. 2008. PMID: 18408575 Free PMC article.
-
Qualitative Perfusion Cardiac Magnetic Resonance Imaging Lacks Sensitivity in Detecting Cardiac Allograft Vasculopathy.Cardiol Res. 2011 Dec;2(6):282-287. doi: 10.4021/cr105w. Epub 2011 Nov 20. Cardiol Res. 2011. PMID: 28352396 Free PMC article.